NCT06756100Recruiting
Early Inflammatory Bowel Disease Progression
Composition and Metabolic Activity of Gut Microbiota to Predict Early Inflammatory Bowel Disease Progression
Source: ClinicalTrials.gov · Last updated 1 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 140 (estimated)
- First submitted
- 30 Sept 2024
- Start date
- 7 Jul 2023
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- Pontificia Universidad Catolica de Chile
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT06756100
What you commit to
- Study type: Observational
- Planned participants: 140
- From 7 Jul 2023 to the primary completion date, 30 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Confirmed infectious disease of the gastrointestinal tract
Who the study is looking for
- Adult patients with with at least 3 weeks of gastrointestinal symptoms including diarrhea, rectal bleeding, abdominal pain, tenesmus or urgency
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pontificia Universidad Catolica of Chile Coordinator of this site? Confirm its status | Santiago | Chile | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.